看來載入頁面時發生了錯誤.
我們的團隊已收到通知，但若此問題持續，請透過電郵支援widget工具聯絡我們。
| Metrics | Range | Conclusion |
|---|---|---|
| Selected LTM Ps Multiple | 7.5x - 8.3x | 7.9x |
| Selected Fwd Ps Multiple | 3.2x - 3.5x | 3.4x |
| Fair Value | $6.96 - $7.69 | $7.33 |
| Upside | 26.3% - 39.6% | 33.0% |
| Benchmarks | Ticker | Full Ticker |
|---|---|---|
| Yield10 Bioscience, Inc. | - | OTCPK:YTEN.Q |
| Dyadic International, Inc. | - | NasdaqCM:DYAI |
| Onconetix, Inc. | - | NasdaqCM:ONCO |
| Cardiff Oncology, Inc. | - | NasdaqCM:CRDF |
| Geron Corporation | - | NasdaqGS:GERN |
| TriSalus Life Sciences, Inc. | - | NasdaqGM:TLSI |
| Select Price / LTM Sales Ratio | ||||||||
| Benchmark Companies | ||||||||
| YTEN.Q | DYAI | ONCO | CRDF | GERN | TLSI | |||
| OTCPK:YTEN.Q | NasdaqCM:DYAI | NasdaqCM:ONCO | NasdaqCM:CRDF | NasdaqGS:GERN | NasdaqGM:TLSI | |||
| Historical Sales Growth | ||||||||
| 5Y CAGR | -35.9% | 15.8% | NM- | 22.8% | 178.4% | NM- | ||
| 3Y CAGR | -57.8% | 13.3% | NM- | 23.9% | 280.9% | 51.9% | ||
| Latest Twelve Months | 190.7% | 20.6% | NM | 40.0% | 32386.9% | 59.0% | ||
| Historical Net Income Profit Margin | ||||||||
| 5 Year Average Margin | -3739.9% | -404.2% | -19098.5% | -7594.3% | -23982.0% | -310.8% | ||
| Prior Fiscal Year | -3014.7% | -234.4% | NA | -8496.9% | -77690.7% | -341.8% | ||
| Latest Fiscal Year | -24091.7% | -166.2% | -63986.5% | -6655.2% | -226.7% | -112.9% | ||
| Latest Twelve Months | -1693.6% | -166.2% | -2758.7% | -6655.2% | -226.7% | -112.9% | ||
| Current Trading Multiples | ||||||||
| EV / LTM EBITDA | -0.2x | NA | -1.3x | -1.5x | -2.9x | -5.3x | ||
| Price / LTM Sales | 0.0x | 10.7x | 0.3x | 240.6x | 11.4x | 5.9x | ||
| LTM P/E Ratio | 0.0x | -6.4x | 0.0x | -3.6x | -5.0x | -5.2x | ||
| Low | Mid | High | ||||||
| Benchmark LTM P/S Ratio | 0.0x | 10.7x | 240.6x | |||||
| Historical LTM P/S Ratio | 5.9x | 13.9x | 26.7x | |||||
| Selected Price / Sales Multiple | 7.5x | 7.9x | 8.3x | |||||
| (x) LTM Sales | 29 | 29 | 29 | |||||
| (=) Equity Value | 220 | 232 | 244 | |||||
| (/) Shares Outstanding | 31.3 | 31.3 | 31.3 | |||||
| Implied Value Range | 7.04 | 7.41 | 7.78 | |||||
| FX Rate: USD/USD | 1.0 | 1.0 | 1.0 | Market Price | ||||
| Implied Value Range (Trading Cur) | 7.04 | 7.41 | 7.78 | 5.51 | ||||
| Upside / (Downside) | 27.8% | 34.6% | 41.3% | |||||
| Equity Value | |||||||
| Benchmark Companies | |||||||
| (in millions) | YTEN.Q | DYAI | ONCO | CRDF | GERN | TLSI | |
| Value of Common Equity | 0 | 37 | 1 | 164 | 879 | 172 | |
| (/) Shares Outstanding | 0.7 | 30.1 | 8.3 | 66.5 | 636.9 | 31.3 | |
| Implied Stock Price | 0.02 | 1.24 | 0.06 | 2.47 | 1.38 | 5.51 | |
| FX Conversion Rate to Trading Currency | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | |
| Implied Stock Price (Trading Cur) | 0.02 | 1.24 | 0.06 | 2.47 | 1.38 | 5.51 | |
| Trading Currency | USD | USD | USD | USD | USD | USD | |
| FX Rate to Reporting Currency | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | |